Answers are grounded in this paper and cite their sources.
Introduction Topical autologous regenerative formulations derived from platelet-rich formulations represent a promising strategy to accelerate skin repair and restore dermal homeostasis. However, the need for multiple blood extractions limits their widespread use. Endoret-Serum, an autologous Plasma Rich in Growth Factors (PRGF)-derived colloidal dispersion overcomes this limitation by providing a topical formulation previously reported to preserve biological activity during storage. The present study aimed to comprehensively characterize Endoret-Serum in terms of its physical properties and to assess its dose-dependent regenerative and immunomodulatory in vitro effects. Methods Rheological behavior, spreadability, physical stability, and protein release kinetics were characterized to evaluate the formulation’s physicochemical properties. Its biological activity was assessed using human dermal fibroblasts under healthy, inflammatory, and UV-induced photoaging conditions by evaluating cell proliferation, migration, collagen synthesis, oxidative stress, synthesis of growth factors and inflammatory mediators and extracellular matrix remodeling. These findings were further confirmed in human photoaged skin explants. Results Rheological and stability evaluations demonstrated pronounced shear-thinning behavior, comparable baseline consistency, enhanced spreadability, and greater physical stability under the tested accelerated conditions. Moreover, it exhibited a sustained release profile that maintained bioactive protein levels within the in vitro regenerative range for at least 72 h. In vitro , Endoret-Serum exerted dose-dependent regenerative, antioxidant and immunomodulatory effects at concentrations ≥2.5% (v/v). Ex vivo studies confirmed preservation of metabolic activity and increased soluble collagen and elastin content (p ≤ 0.01). Discussion Endoret-Serum combines favorable physicochemical properties with sustained bioactive protein release and potent regenerative and immunomodulatory activity, supporting its potential as a topically applicable autologous biomaterial for cutaneous regeneration. These findings provide a strong preclinical rationale for its further translational and clinical evaluation.
No takes yet. Share an insight, caveat, or question.
Anitua et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: